24×7 Online Assistance Email researchnnnn@gmail.com WhatsApp support Hours 24×7
MD · Diagnostic

Immunohaematology & Blood Transfusion MD Thesis Topics — 220+ titles

Updated November 2026 · reviewed against the current NMC / NBE curriculum

Hand-curated database of 220+ MD Immunohaematology & Blood Transfusion dissertation titles, each ready with objectives, synopsis structure and protocol guidance. Unlock the objectives of any title instantly, or get the complete thesis plan — no signup.

220+MD Immunohaematology & Blood Transfusion titles
24×7Instant objectives & thesis plans
100%Plagiarism-free, IEC-ready
Browse all 220 titles Free sample objectives See a full thesis plan

MD Immunohaematology & Blood Transfusion — Thesis Title List

220 titles · instant objectives
  1. 001

    Seroprevalence and trends of transfusion-transmitted infections (HIV, HBV, HCV, syphilis, malaria) among blood donors over five years

    Donor Screening & TTI Retrospective record-based study Cross-sectional Study
    Objective
  2. 002

    Comparison of nucleic acid testing versus serological screening for detection of HBV, HCV and HIV in blood donors

    Donor Screening & TTI Prospective comparative study Diagnostic Accuracy Study
    Objective
  3. 003

    Pattern and causes of blood donor deferral at a tertiary care blood centre and its impact on donor return

    Donor Screening & TTI Prospective observational study Cross-sectional Study
    Objective
  4. 004

    Prevalence of occult hepatitis B infection among HBsAg-negative, anti-HBc-positive blood donors

    Donor Screening & TTI Prospective observational study Cross-sectional Study
    Objective
  5. 005

    Iron status and prevalence of iron deficiency among regular voluntary blood donors

    Donor Screening & TTI Cross-sectional study Cross-sectional Study
    Objective
  6. 006

    Adverse donor reactions during whole blood and apheresis donation: incidence, types and risk factors

    Donor Screening & TTI Prospective observational study Prospective Study
    Objective
  7. 007

    Knowledge, attitude and practice regarding voluntary blood donation among college students and effect of an awareness intervention

    Donor Screening & TTI Pre-post interventional study KAP Study
    Objective
  8. 008

    Prevalence of ABO, Rh and other clinically significant blood group antigens among blood donors in a regional population

    Immunohaematology Cross-sectional study Cross-sectional Study
    Objective
  9. 009

    Prevalence and specificity of red cell alloantibodies in multi-transfused thalassaemia patients

    Immunohaematology Hospital-based cross-sectional study Cross-sectional Study
    Objective
  10. 010

    Comparison of gel card technique versus conventional tube technique for antibody screening and cross-matching

    Immunohaematology Prospective comparative study Method Comparison Study
    Objective
  11. 011

    Red cell alloimmunisation in antenatal women: prevalence, antibody specificity and fetal outcome

    Immunohaematology Prospective observational study Cross-sectional Study
    Objective
  12. 012

    ABO discrepancies encountered in routine blood grouping: frequency, causes and resolution

    Immunohaematology Prospective observational study Descriptive Study
    Objective
  13. 013

    Extended red cell antigen phenotyping in sickle cell disease and thalassaemia patients to prevent alloimmunisation

    Immunohaematology Prospective observational study Prospective Study
    Objective
  14. 014

    Direct antiglobulin test positivity in patients and blood donors: causes and clinical significance

    Immunohaematology Prospective observational study Cross-sectional Study
    Objective
  15. 015

    Audit of blood component utilisation and appropriateness of transfusion requests against national guidelines

    Clinical Transfusion Practice Prospective audit Audit
    Objective
  16. 016

    Implementation of a maximum surgical blood order schedule and its effect on cross-match to transfusion ratio

    Clinical Transfusion Practice Pre-post interventional study Quality Improvement Study
    Objective
  17. 017

    Single-unit versus double-unit red cell transfusion policy in haemodynamically stable anaemic inpatients

    Clinical Transfusion Practice Prospective comparative study Comparative Study
    Objective
  18. 018

    Pattern of platelet transfusion in dengue and adherence to transfusion guidelines

    Clinical Transfusion Practice Prospective audit Audit
    Objective
  19. 019

    Transfusion practices in obstetric haemorrhage and outcome of massive transfusion protocol implementation

    Clinical Transfusion Practice Pre-post interventional study Quality Improvement Study
    Objective
  20. 020

    Preoperative anaemia management and its effect on perioperative transfusion in elective surgery: a patient blood management approach

    Clinical Transfusion Practice Prospective interventional study Interventional Study
    Objective
  21. 021

    Wastage of blood components at a tertiary care blood centre: causes and corrective measures

    Clinical Transfusion Practice Retrospective record-based audit Audit
    Objective
  22. 022

    Incidence, types and reporting of adverse transfusion reactions under haemovigilance at a tertiary care hospital

    Haemovigilance Prospective observational study Prospective Study
    Objective
  23. 023

    Febrile non-haemolytic transfusion reactions: incidence with leucoreduced versus non-leucoreduced components

    Haemovigilance Prospective comparative study Comparative Study
    Objective
  24. 024

    Transfusion-associated circulatory overload and TRALI in the ICU: incidence and risk factors

    Haemovigilance Prospective observational study Prospective Study
    Objective
  25. 025

    Near-miss events and bedside transfusion errors: a prospective audit of transfusion practice on the wards

    Haemovigilance Prospective audit Audit
    Objective
  26. 026

    Knowledge and practice of nurses and residents regarding safe blood transfusion and effect of a training module

    Haemovigilance Pre-post interventional study KAP Study
    Objective
  27. 027

    Quality control of packed red cells, platelet concentrates and fresh frozen plasma prepared by different methods

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  28. 028

    Comparison of platelet-rich plasma versus buffy coat method for platelet concentrate preparation: yield and quality

    Component Preparation & Quality Prospective comparative study Comparative Study
    Objective
  29. 029

    Storage lesions in packed red cells: biochemical and haematological changes over the shelf life

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  30. 030

    Bacterial contamination of platelet concentrates: prevalence and effect of diversion pouch and skin disinfection

    Component Preparation & Quality Prospective observational study Cross-sectional Study
    Objective
  31. 031

    Effect of storage duration of transfused red cells on clinical outcome in critically ill and cardiac surgery patients

    Component Preparation & Quality Prospective observational study Prospective Study
    Objective
  32. 032

    Single-donor apheresis platelets versus random donor platelets in thrombocytopenic patients: corrected count increment and reactions

    Apheresis Prospective comparative study Comparative Study
    Objective
  33. 033

    Therapeutic plasma exchange in neurological and haematological disorders: indications, complications and outcome

    Apheresis Prospective observational study Descriptive Study
    Objective
  34. 034

    Outcome of therapeutic plasma exchange in thrombotic thrombocytopenic purpura and Guillain-Barre syndrome

    Apheresis Prospective observational study Prospective Study
    Objective
  35. 035

    Peripheral blood stem cell collection by apheresis: factors affecting CD34+ yield and donor adverse events

    Apheresis Prospective observational study Prospective Study
    Objective
  36. 036

    Red cell exchange in sickle cell disease: indications, efficacy and complications

    Apheresis Prospective observational study Descriptive Study
    Objective
  37. 037

    Transfusion requirements, alloimmunisation and iron overload in transfusion-dependent thalassaemia patients

    Transfusion in Special Groups Hospital-based cross-sectional study Cross-sectional Study
    Objective
  38. 038

    Neonatal transfusion practices and adverse events in a tertiary care NICU

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  39. 039

    Platelet transfusion thresholds and outcomes in patients with haematological malignancies on chemotherapy

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  40. 040

    Blood component usage in cardiac surgery and effect of point-of-care coagulation testing on transfusion

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  41. 041

    Intrauterine transfusion for Rh alloimmunised pregnancies: outcome and complications

    Transfusion in Special Groups Retrospective record-based study Descriptive Study
    Objective
  42. 042

    Platelet refractoriness in multi-transfused patients: prevalence, HLA alloimmunisation and management

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  43. 043

    Convalescent plasma and immunoglobulin preparations: donor selection and antibody titre evaluation

    Plasma & Derivatives Prospective laboratory study Analytical Study
    Objective
  44. 044

    Cryoprecipitate versus fibrinogen concentrate in acquired hypofibrinogenaemia: efficacy and safety

    Plasma & Derivatives Prospective comparative study Comparative Study
    Objective
  45. 045

    Appropriateness of fresh frozen plasma transfusion and effect of prospective review on utilisation

    Plasma & Derivatives Pre-post interventional study Audit
    Objective
  46. 046

    Establishment and utilisation of a rare blood group donor registry at a regional blood centre

    Blood Centre Management Prospective observational study Descriptive Study
    Objective
  47. 047

    Blood inventory management and expiry rates: effect of a computerised inventory system

    Blood Centre Management Pre-post interventional study Quality Improvement Study
    Objective
  48. 048

    Cost analysis of blood component preparation and pricing at a public blood centre

    Blood Centre Management Cross-sectional cost analysis Cost Analysis
    Objective
  49. 049

    Turnaround time of cross-matching and issue of blood in emergencies and effect of an emergency issue protocol

    Blood Centre Management Pre-post interventional study Quality Improvement Study
    Objective
  50. 050

    Prevalence of weak D and partial D phenotypes among Rh-negative donors and antenatal women

    Immunohaematology Prospective observational study Cross-sectional Study
    Objective
  51. 051

    Autoimmune haemolytic anaemia: serological characterisation and transfusion management

    Immunohaematology Prospective observational study Descriptive Study
    Objective
  52. 052

    Pathogen reduction technology for platelets: effect on quality parameters and clinical efficacy

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  53. 053

    Motivators and barriers to repeat voluntary blood donation among first-time donors

    Donor Screening & TTI Cross-sectional questionnaire-based study Cross-sectional Study
    Objective
  54. 054

    Haemoglobin estimation methods for donor screening: comparison of copper sulphate, HemoCue and automated analyser

    Donor Screening & TTI Prospective comparative study Method Comparison Study
    Objective
  55. 055

    Transfusion support in dengue: platelet utilisation, thresholds and outcome across severity grades

    Clinical Transfusion Practice Prospective observational study Prospective Study
    Objective
  56. 056

    Seroprevalence of syphilis among blood donors and comparison of RPR with a treponemal chemiluminescence assay

    Donor Screening & TTI Prospective laboratory study Method Comparison Study
    Objective
  57. 057

    Association of ABO blood groups with transfusion-transmitted infection reactivity among blood donors

    Donor Screening & TTI Retrospective record-based study Analytical Study
    Objective
  58. 058

    Effect of a distraction intervention on needle fear and vasovagal reactions in first-time blood donors

    Donor Screening & TTI Prospective interventional study Interventional Study
    Objective
  59. 059

    Ferritin-guided versus standard donation intervals in regular whole blood donors: iron status and deferral

    Donor Screening & TTI Prospective comparative study Comparative Study
    Objective
  60. 060

    Seroprevalence of HTLV-I/II antibodies among blood donors in a regional population

    Donor Screening & TTI Prospective laboratory study Cross-sectional Study
    Objective
  61. 061

    Rapid antigen test versus peripheral smear microscopy for malaria screening of blood donors

    Donor Screening & TTI Prospective laboratory study Method Comparison Study
    Objective
  62. 062

    Dengue NS1 antigen among asymptomatic blood donors during the monsoon season

    Donor Screening & TTI Prospective laboratory study Cross-sectional Study
    Objective
  63. 063

    Effect of oral iron supplementation on haemoglobin and ferritin in female repeat blood donors

    Donor Screening & TTI Prospective interventional study Interventional Study
    Objective
  64. 064

    Seroprevalence of hepatitis E virus antibodies among blood donors

    Donor Screening & TTI Prospective laboratory study Cross-sectional Study
    Objective
  65. 065

    Disclosure of high-risk behaviour through a confidential pre-donation questionnaire among blood donors

    Donor Screening & TTI Cross-sectional questionnaire-based study Cross-sectional Study
    Objective
  66. 066

    Donor notification and follow-up of transfusion-transmitted infection reactive donors for confirmatory testing

    Donor Screening & TTI Prospective observational study Descriptive Study
    Objective
  67. 067

    Maternal red cell antibody screening in antenatal women and its association with neonatal hyperbilirubinaemia

    Immunohaematology Prospective observational study Prospective Study
    Objective
  68. 068

    Red cell alloimmunisation in multi-transfused patients with chronic kidney disease and haematological malignancies

    Immunohaematology Hospital-based cross-sectional study Cross-sectional Study
    Objective
  69. 069

    RHD genotyping of serologically weak D blood donors and antenatal women

    Immunohaematology Prospective laboratory study Method Comparison Study
    Objective
  70. 070

    Column agglutination versus solid-phase red cell adherence assay for antibody screening

    Immunohaematology Prospective laboratory study Method Comparison Study
    Objective
  71. 071

    Daratumumab interference in pre-transfusion testing and its resolution with dithiothreitol-treated red cells

    Immunohaematology Prospective laboratory study Descriptive Study
    Objective
  72. 072

    Anti-A and anti-B titres in group O platelet donors and risk of haemolysis with out-of-group platelet transfusion

    Immunohaematology Prospective laboratory study Analytical Study
    Objective
  73. 073

    Gel versus tube antibody titration in Rh-alloimmunised pregnancies

    Immunohaematology Prospective laboratory study Method Comparison Study
    Objective
  74. 074

    Frequency of Kell, Duffy, Kidd and MNS antigens among blood donors for an antigen-negative red cell inventory

    Immunohaematology Prospective laboratory study Cross-sectional Study
    Objective
  75. 075

    Monospecific direct antiglobulin test profile in autoimmune haemolytic anaemia and its correlation with severity of haemolysis

    Immunohaematology Prospective laboratory study Analytical Study
    Objective
  76. 076

    Electronic versus serological cross-match: turnaround time and safety

    Immunohaematology Prospective comparative study Comparative Study
    Objective
  77. 077

    Irregular red cell antibodies in pre-transfusion patients: prevalence and specificity

    Immunohaematology Prospective observational study Cross-sectional Study
    Objective
  78. 078

    Cold agglutinin interference in ABO and Rh grouping and methods of resolution

    Immunohaematology Prospective laboratory study Descriptive Study
    Objective
  79. 079

    Pre-operative iron deficiency screening and intravenous iron in cardiac surgery: effect on transfusion

    Clinical Transfusion Practice Pre-post interventional study Interventional Study
    Objective
  80. 080

    Adherence to restrictive transfusion thresholds in upper gastrointestinal bleeding and outcome

    Clinical Transfusion Practice Prospective audit Audit
    Objective
  81. 081

    Risk factors for repeat platelet transfusion in thrombocytopenic inpatients

    Clinical Transfusion Practice Prospective observational study Analytical Study
    Objective
  82. 082

    Platelet transfusion before central venous catheter insertion in thrombocytopenic patients: practice and bleeding

    Clinical Transfusion Practice Prospective audit Audit
    Objective
  83. 083

    Patient blood management programme in hip and knee arthroplasty: effect on transfusion rate

    Clinical Transfusion Practice Pre-post interventional study Quality Improvement Study
    Objective
  84. 084

    Tranexamic acid use and transfusion requirement in elective surgery: an audit

    Clinical Transfusion Practice Retrospective record-based audit Audit
    Objective
  85. 085

    Pre-transfusion haemoglobin triggers in medical wards and adherence to restrictive thresholds

    Clinical Transfusion Practice Prospective audit Audit
    Objective
  86. 086

    Blood component requirements in haematopoietic stem cell transplant recipients

    Clinical Transfusion Practice Prospective observational study Descriptive Study
    Objective
  87. 087

    Plasma to red cell ratio in massive transfusion for trauma and its association with outcome

    Clinical Transfusion Practice Prospective observational study Prospective Study
    Objective
  88. 088

    Electronic decision support for blood requests and its effect on inappropriate plasma and platelet requests

    Clinical Transfusion Practice Pre-post interventional study Quality Improvement Study
    Objective
  89. 089

    Emergency release of uncrossmatched group O red cells: indications and safety outcomes

    Clinical Transfusion Practice Prospective observational study Descriptive Study
    Objective
  90. 090

    Viscoelastic testing-guided versus conventional transfusion in postpartum haemorrhage: blood product use

    Clinical Transfusion Practice Prospective comparative study Comparative Study
    Objective
  91. 091

    Knowledge, attitude and practice of postgraduate residents regarding haemovigilance and transfusion reaction reporting

    Haemovigilance Cross-sectional questionnaire-based study KAP Study
    Objective
  92. 092

    Active surveillance versus passive reporting for detection of transfusion reactions

    Haemovigilance Prospective comparative study Comparative Study
    Objective
  93. 093

    Allergic transfusion reactions to platelets and plasma: incidence and premedication practices

    Haemovigilance Prospective observational study Prospective Study
    Objective
  94. 094

    Delayed haemolytic and serological transfusion reactions in multi-transfused patients

    Haemovigilance Prospective observational study Prospective Study
    Objective
  95. 095

    Compliance with vital sign monitoring during blood transfusion on the wards

    Haemovigilance Prospective audit Audit
    Objective
  96. 096

    Pre-transfusion risk assessment checklist for transfusion-associated circulatory overload in elderly patients

    Haemovigilance Pre-post interventional study Quality Improvement Study
    Objective
  97. 097

    Delayed adverse events after whole blood donation detected by telephone follow-up

    Haemovigilance Prospective observational study Prospective Study
    Objective
  98. 098

    Root cause analysis of transfusion errors and near misses reported to the blood centre

    Haemovigilance Retrospective record-based study Descriptive Study
    Objective
  99. 099

    Two-sample policy for ABO grouping and detection of wrong blood in tube errors

    Haemovigilance Pre-post interventional study Quality Improvement Study
    Objective
  100. 100

    Barcode-based patient identification and its effect on bedside transfusion errors

    Haemovigilance Pre-post interventional study Quality Improvement Study
    Objective
  101. 101

    Hypotensive transfusion reactions and their association with ACE inhibitor use

    Haemovigilance Prospective observational study Analytical Study
    Objective
  102. 102

    Donor age and sex and their association with oxidative stress markers in stored platelet concentrates

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  103. 103

    Platelet storage lesion over five days in buffy coat versus apheresis platelets

    Component Preparation & Quality Prospective comparative study Comparative Study
    Objective
  104. 104

    Fibrinogen and factor VIII content of cryoprecipitate prepared by different thawing methods

    Component Preparation & Quality Prospective laboratory study Method Comparison Study
    Objective
  105. 105

    Haemolysis in SAGM-stored red cells and its association with donor characteristics

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  106. 106

    Residual leucocyte count in leucoreduced red cells with different filtration methods

    Component Preparation & Quality Prospective laboratory study Method Comparison Study
    Objective
  107. 107

    Whole blood holding time before component separation and its effect on factor VIII in plasma

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  108. 108

    Bacterial contamination of blood components detected by automated culture

    Component Preparation & Quality Prospective laboratory study Cross-sectional Study
    Objective
  109. 109

    Potassium leak and haemolysis in gamma-irradiated red cells over storage

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  110. 110

    Automated component extractor versus manual separation: quality of red cells, platelets and plasma

    Component Preparation & Quality Prospective comparative study Method Comparison Study
    Objective
  111. 111

    Platelet swirling as a quality indicator and its correlation with platelet count and pH

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  112. 112

    Overnight room-temperature hold of whole blood and its effect on platelet concentrate quality

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  113. 113

    Adverse events in plateletpheresis donors: prevalence and predictors

    Apheresis Prospective observational study Prospective Study
    Objective
  114. 114

    Pre-donation platelet count and donor weight as predictors of plateletpheresis yield

    Apheresis Prospective observational study Analytical Study
    Objective
  115. 115

    Double-dose plateletpheresis: donor safety and product quality

    Apheresis Prospective observational study Prospective Study
    Objective
  116. 116

    Therapeutic plasma exchange in neuromyelitis optica spectrum disorder and myasthenic crisis: response and complications

    Apheresis Prospective observational study Prospective Study
    Objective
  117. 117

    Therapeutic plasma exchange in acute liver failure: biochemical response and transplant-free survival

    Apheresis Prospective observational study Prospective Study
    Objective
  118. 118

    Albumin versus albumin with plasma as replacement fluid in therapeutic plasma exchange: coagulation changes

    Apheresis Prospective comparative study Comparative Study
    Objective
  119. 119

    Leukapheresis for hyperleucocytosis in acute leukaemia: efficacy and complications

    Apheresis Prospective observational study Descriptive Study
    Objective
  120. 120

    Therapeutic plasma exchange in snake envenomation-associated thrombotic microangiopathy

    Apheresis Prospective observational study Descriptive Study
    Objective
  121. 121

    Iron status of repeat plateletpheresis donors

    Apheresis Cross-sectional study Cross-sectional Study
    Objective
  122. 122

    Satisfaction and return rate of first-time apheresis donors

    Apheresis Cross-sectional questionnaire-based study Cross-sectional Study
    Objective
  123. 123

    Prophylactic oral calcium for citrate-related symptoms during plateletpheresis

    Apheresis Prospective interventional study Interventional Study
    Objective
  124. 124

    Probable sarcopenia and bone health in transfusion-dependent beta thalassaemia

    Transfusion in Special Groups Hospital-based cross-sectional study Cross-sectional Study
    Objective
  125. 125

    Pre-transfusion haemoglobin, chelation adherence and serum ferritin in transfusion-dependent thalassaemia

    Transfusion in Special Groups Prospective observational study Analytical Study
    Objective
  126. 126

    Neonatal exchange transfusion: indications, component use and adverse events

    Transfusion in Special Groups Prospective observational study Descriptive Study
    Objective
  127. 127

    Platelet transfusion thresholds in preterm neonates: practice and bleeding outcomes

    Transfusion in Special Groups Prospective audit Audit
    Objective
  128. 128

    Blood component requirements in living donor liver transplantation

    Transfusion in Special Groups Prospective observational study Descriptive Study
    Objective
  129. 129

    Alloimmunisation and delayed haemolytic reactions in transfused patients with sickle cell disease

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  130. 130

    Red cell transfusion for anaemia of prematurity: practice and outcome

    Transfusion in Special Groups Prospective audit Audit
    Objective
  131. 131

    Alloimmunisation and platelet refractoriness in patients with aplastic anaemia

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  132. 132

    Maximum surgical blood order schedule for obstetric procedures

    Transfusion in Special Groups Retrospective record-based study Quality Improvement Study
    Objective
  133. 133

    Transfusion thresholds and adverse events in paediatric oncology patients

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  134. 134

    Quality of life in children with transfusion-dependent thalassaemia and its association with serum ferritin

    Transfusion in Special Groups Hospital-based cross-sectional study Cross-sectional Study
    Objective
  135. 135

    Protein content and sterility of recovered plasma supplied for fractionation

    Plasma & Derivatives Prospective laboratory study Analytical Study
    Objective
  136. 136

    Fresh frozen plasma versus prothrombin complex concentrate for warfarin reversal

    Plasma & Derivatives Prospective comparative study Comparative Study
    Objective
  137. 137

    Stability of coagulation factors in thawed plasma stored for five days

    Plasma & Derivatives Prospective laboratory study Analytical Study
    Objective
  138. 138

    Appropriateness of human albumin use in a tertiary care hospital

    Plasma & Derivatives Prospective audit Audit
    Objective
  139. 139

    Utilisation and appropriateness of intravenous immunoglobulin in a tertiary care hospital

    Plasma & Derivatives Retrospective record-based audit Audit
    Objective
  140. 140

    Cryoprecipitate use and fibrinogen levels in obstetric haemorrhage

    Plasma & Derivatives Prospective observational study Prospective Study
    Objective
  141. 141

    Plasma wastage at a blood centre and effect of corrective measures

    Plasma & Derivatives Pre-post interventional study Quality Improvement Study
    Objective
  142. 142

    Fibrinogen concentration in fresh frozen plasma by donor ABO group

    Plasma & Derivatives Prospective laboratory study Analytical Study
    Objective
  143. 143

    Factor VIII yield in cryoprecipitate from group O versus non-O donors

    Plasma & Derivatives Prospective laboratory study Analytical Study
    Objective
  144. 144

    Plasma transfusion in dengue with bleeding: indications and outcome

    Plasma & Derivatives Prospective observational study Descriptive Study
    Objective
  145. 145

    Donor yield and deferral pattern in outdoor blood donation camps versus in-house donation

    Blood Centre Management Retrospective record-based study Comparative Study
    Objective
  146. 146

    Effect of SMS reminders on return rate of voluntary blood donors

    Blood Centre Management Prospective interventional study Interventional Study
    Objective
  147. 147

    Seasonal variation in blood collection and demand and its implications for inventory planning

    Blood Centre Management Retrospective record-based study Analytical Study
    Objective
  148. 148

    Monitoring of blood centre quality indicators against NABH standards

    Blood Centre Management Prospective audit Quality Improvement Study
    Objective
  149. 149

    Cold chain compliance during transport of blood components to peripheral hospitals

    Blood Centre Management Prospective audit Audit
    Objective
  150. 150

    Effect of a laboratory information system on turnaround time and clerical errors in a blood centre

    Blood Centre Management Pre-post interventional study Quality Improvement Study
    Objective
  151. 151

    Utilisation and wastage at blood storage centres in first referral units

    Blood Centre Management Cross-sectional study Descriptive Study
    Objective
  152. 152

    Cost per unit of single-donor apheresis platelets versus random donor platelets

    Blood Centre Management Cross-sectional cost analysis Cost Analysis
    Objective
  153. 153

    Performance in external quality assessment for immunohaematology and corrective actions

    Blood Centre Management Prospective audit Quality Improvement Study
    Objective
  154. 154

    Effect of a training programme on staff competency in blood grouping and cross-matching

    Blood Centre Management Pre-post interventional study Interventional Study
    Objective
  155. 155

    Effectiveness of the donor questionnaire in detecting high-risk behaviour among donors reactive for transfusion-transmitted infections

    Donor Screening & TTI Retrospective record-based study Analytical Study
    Objective
  156. 156

    TPHA versus RPR and chemiluminescence assays for syphilis screening in blood donors at a tertiary-care blood centre

    Donor Screening & TTI Prospective comparative study Method Comparison Study
    Objective
  157. 157

    Seroprevalence of anti-hepatitis E virus IgG among voluntary blood donors at a tertiary-care blood centre

    Donor Screening & TTI Cross-sectional study Cross-sectional Study
    Objective
  158. 158

    Response of TTI-reactive blood donors to notification and their uptake of confirmatory testing and referral

    Donor Screening & TTI Prospective observational study Cross-sectional Study
    Objective
  159. 159

    Clinical spectrum, associated antibodies and transfusion outcome in patients with anti-E alloantibody at a tertiary-care hospital

    Immunohaematology Retrospective record-based study Descriptive Study
    Objective
  160. 160

    Molecular characterisation of RhD variants in donors and patients with serological RhD typing discrepancies

    Immunohaematology Prospective laboratory study Prospective Study
    Objective
  161. 161

    Gel card versus conventional tube technique for anti-A and anti-B titres before ABO-incompatible renal transplantation

    Immunohaematology Prospective comparative study Method Comparison Study
    Objective
  162. 162

    Blood component ordering and utilisation in obstetric haemorrhage according to underlying cause at a tertiary-care hospital

    Clinical Transfusion Practice Prospective observational study Prospective Study
    Objective
  163. 163

    Plasma and platelet to red cell ratios during early resuscitation and 24-hour mortality in severely injured trauma patients

    Clinical Transfusion Practice Prospective observational study Prospective Study
    Objective
  164. 164

    Tranexamic acid use and blood component requirement in women with postpartum haemorrhage at a tertiary-care hospital

    Clinical Transfusion Practice Prospective observational study Prospective Study
    Objective
  165. 165

    Validation of a symptom-based tool for classification of acute transfusion reactions against standard haemovigilance definitions

    Haemovigilance Prospective observational study Diagnostic Accuracy Study
    Objective
  166. 166

    Allergic transfusion reactions with plasma and platelet components and their recurrence on subsequent transfusions

    Haemovigilance Retrospective record-based study Descriptive Study
    Objective
  167. 167

    Effect of pre-donation water loading on vasovagal reactions in first-time young whole blood donors

    Haemovigilance Prospective interventional study Interventional Study
    Objective
  168. 168

    In vitro storage quality of apheresis platelets in different platelet additive solutions over five days of storage

    Component Preparation & Quality Prospective comparative study Comparative Study
    Objective
  169. 169

    Optimal number of ABO-matched buffy coats per pool to achieve an adult platelet dose comparable to single donor platelets

    Component Preparation & Quality Prospective comparative study Comparative Study
    Objective
  170. 170

    Storage lesion markers including LDH and haemolysis in packed red cells stored up to 15 days versus beyond 15 days

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  171. 171

    Residual leucocyte counts and red cell recovery with bedside versus pre-storage leucofiltration of red cell units

    Component Preparation & Quality Prospective comparative study Comparative Study
    Objective
  172. 172

    Effect of an awareness drive on knowledge and willingness for plateletpheresis donation among undergraduate medical students

    Apheresis Pre-post interventional study KAP Study
    Objective
  173. 173

    Red cell transfusion practice before therapeutic leukapheresis in patients with hyperleukocytosis at a tertiary-care centre

    Apheresis Retrospective record-based study Descriptive Study
    Objective
  174. 174

    Platelet count recovery and haematological changes in repeat plateletpheresis donors over the inter-donation interval

    Apheresis Prospective observational study Prospective Study
    Objective
  175. 175

    Predictors of CD34-positive cell yield in autologous peripheral blood stem cell harvest at a tertiary-care centre

    Apheresis Prospective observational study Prospective Study
    Objective
  176. 176

    Frequency of multiple red cell alloantibodies and use of adsorption-elution techniques in multiply transfused HbE-beta-thalassaemia patients

    Transfusion in Special Groups Retrospective record-based study Descriptive Study
    Objective
  177. 177

    Physiological versus time-based delayed cord clamping and need for red cell transfusion in preterm neonates

    Transfusion in Special Groups Prospective comparative study Comparative Study
    Objective
  178. 178

    Red cell and platelet transfusion requirement during induction chemotherapy in adults with acute myeloid leukaemia

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  179. 179

    Total protein and factor VIII levels in recovered plasma units meeting quality requirements for fractionation

    Plasma & Derivatives Prospective laboratory study Analytical Study
    Objective
  180. 180

    Factor VIII and fibrinogen levels in plasma frozen within 8 hours versus within 24 hours of whole blood collection

    Plasma & Derivatives Prospective comparative study Comparative Study
    Objective
  181. 181

    Process excellence tools to reduce turnaround time for issue of blood components at a tertiary-care blood centre

    Blood Centre Management Pre-post interventional study Quality Improvement Study
    Objective
  182. 182

    Effect of a visual inventory display system on outdating and wastage of red cell units in a hospital-based blood centre

    Blood Centre Management Pre-post interventional study Quality Improvement Study
    Objective
  183. 183

    Westgard rule-based internal quality control for transfusion-transmitted infection ELISA testing in a blood centre

    Blood Centre Management Prospective audit Quality Improvement Study
    Objective
  184. 184

    Return rate of first-time voluntary blood donors and factors associated with donor retention at a tertiary-care blood centre

    Blood Centre Management Retrospective record-based study Analytical Study
    Objective
  185. 185

    Outdoor camp versus in-house blood collections: donor profile, deferral, adverse reactions and TTI reactivity

    Blood Centre Management Retrospective record-based study Comparative Study
    Objective
  186. 186

    Haemoglobin-based versus physiological triggers including central venous oxygen saturation and lactate for red cell transfusion in ICU patients

    Clinical Transfusion Practice Prospective comparative study Comparative Study
    Objective
  187. 187

    Third-generation versus fourth-generation HIV ELISA for screening of blood donors: reactivity rates and confirmatory test concordance

    Donor Screening & TTI Prospective comparative study Method Comparison Study
    Objective
  188. 188

    First-drop versus second-drop capillary haemoglobin on a portable haemoglobinometer compared with venous analyser values in blood donors

    Donor Screening & TTI Cross-sectional study Method Comparison Study
    Objective
  189. 189

    Telephone call, SMS and WhatsApp messaging compared for promoting repeat donation among first-time voluntary blood donors

    Donor Screening & TTI Prospective interventional study Interventional Study
    Objective
  190. 190

    Transfusion-transmitted infection reactivity in first-time versus repeat voluntary blood donors at a tertiary-care blood centre

    Donor Screening & TTI Retrospective record-based study Comparative Study
    Objective
  191. 191

    Hepatitis B vaccination status and anti-HBs antibody titres among regular voluntary blood donors

    Donor Screening & TTI Hospital-based cross-sectional study Cross-sectional Study
    Objective
  192. 192

    Incidence of HIV, HBV and HCV seroconversion among repeat voluntary blood donors over five years

    Donor Screening & TTI Retrospective record-based study Descriptive Study
    Objective
  193. 193

    Frequency and clinical significance of anti-M and anti-S antibodies among patients with irregular red cell antibodies

    Immunohaematology Retrospective record-based study Cross-sectional Study
    Objective
  194. 194

    Frequency and serological characterisation of weak A and weak B subgroups among blood donors using adsorption-elution and saliva secretor studies

    Immunohaematology Prospective laboratory study Descriptive Study
    Objective
  195. 195

    Frequency of minor blood group alleles and predicted phenotypes in RhD-negative blood donors by molecular genotyping

    Immunohaematology Prospective laboratory study Cross-sectional Study
    Objective
  196. 196

    Fully automated versus semi-automated column agglutination for ABO and RhD grouping: discrepancy rates and turnaround time

    Immunohaematology Prospective comparative study Method Comparison Study
    Objective
  197. 197

    Prevalence of HLA class I antibodies in multiparous female plateletpheresis donors at a tertiary-care blood centre

    Immunohaematology Prospective laboratory study Cross-sectional Study
    Objective
  198. 198

    Development of a maximum surgical blood order schedule for elective neurosurgical procedures at a tertiary-care hospital

    Clinical Transfusion Practice Retrospective record-based audit Audit
    Objective
  199. 199

    Audit of preoperative cross-matching and cross-match to transfusion ratio in major elective paediatric surgical procedures

    Clinical Transfusion Practice Retrospective record-based audit Audit
    Objective
  200. 200

    Appropriateness of red cell transfusion against restrictive haemoglobin thresholds in a paediatric intensive care unit

    Clinical Transfusion Practice Prospective audit Audit
    Objective
  201. 201

    Adherence to antenatal and postnatal anti-D immunoglobulin prophylaxis in RhD-negative women at a tertiary-care hospital

    Clinical Transfusion Practice Prospective audit Audit
    Objective
  202. 202

    Return rate and recurrence of vasovagal reactions among whole blood donors with a previous vasovagal reaction: a three-year follow-up

    Haemovigilance Prospective observational study Prospective Study
    Objective
  203. 203

    Imputability and severity grading of acute transfusion reactions in paediatric patients using ISBT haemovigilance criteria

    Haemovigilance Prospective observational study Prospective Study
    Objective
  204. 204

    Compliance with informed consent for blood transfusion and its documentation in inpatient wards: an audit

    Haemovigilance Prospective audit Audit
    Objective
  205. 205

    Thromboelastography and platelet indices as quality parameters of stored random donor platelet concentrates over five days

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  206. 206

    Haemostatic parameters of cold-stored low-titre group O whole blood over 14 days of storage

    Component Preparation & Quality Prospective laboratory study Analytical Study
    Objective
  207. 207

    Prevalence of lipaemic plasma units and associated donor factors at a tertiary-care blood centre

    Component Preparation & Quality Prospective observational study Cross-sectional Study
    Objective
  208. 208

    Quality of whole blood-derived platelet concentrates prepared from 350 ml versus 450 ml whole blood collections

    Component Preparation & Quality Prospective laboratory study Comparative Study
    Objective
  209. 209

    Therapeutic plasma exchange in patients aged above 60 years: indications, procedure-related complications and clinical response

    Apheresis Prospective observational study Prospective Study
    Objective
  210. 210

    Therapeutic plasma exchange in hypertriglyceridaemia-induced acute pancreatitis: triglyceride reduction and clinical outcome

    Apheresis Prospective observational study Prospective Study
    Objective
  211. 211

    Granulocyte yield and donor adverse events in granulocyte apheresis after steroid or G-CSF mobilisation

    Apheresis Prospective observational study Prospective Study
    Objective
  212. 212

    Risk factors for red cell alloimmunisation in multi-transfused patients with haemoglobinopathies at a tertiary-care centre

    Transfusion in Special Groups Hospital-based cross-sectional study Analytical Study
    Objective
  213. 213

    Preparation, utilisation and wastage of red cell aliquots for neonatal and paediatric transfusion at a hospital-based blood centre

    Transfusion in Special Groups Retrospective record-based study Descriptive Study
    Objective
  214. 214

    Blood component requirement during induction therapy in patients with acute promyelocytic leukaemia

    Transfusion in Special Groups Prospective observational study Prospective Study
    Objective
  215. 215

    Transfusion requirement and red cell alloimmunisation in patients with myelodysplastic syndrome at a tertiary-care hospital

    Transfusion in Special Groups Hospital-based cross-sectional study Cross-sectional Study
    Objective
  216. 216

    Universal plasma prepared by mixing group A and group B plasma with saline: anti-A and anti-B titres and coagulation factor levels

    Plasma & Derivatives Prospective laboratory study Analytical Study
    Objective
  217. 217

    Appropriateness of cryoprecipitate transfusion against fibrinogen levels and indications in a tertiary-care hospital

    Plasma & Derivatives Prospective audit Audit
    Objective
  218. 218

    Time-series forecasting of platelet demand to reduce platelet outdating at a hospital-based blood centre

    Blood Centre Management Pre-post interventional study Quality Improvement Study
    Objective
  219. 219

    Donor satisfaction and its association with intention to return among whole blood donors at a tertiary-care blood centre

    Blood Centre Management Cross-sectional questionnaire-based study Cross-sectional Study
    Objective
  220. 220

    Cost analysis of individual-donor versus minipool nucleic acid testing for blood donor screening at a tertiary-care blood centre

    Blood Centre Management Cross-sectional cost analysis Cost Analysis
    Objective

MD Immunohaematology & Blood Transfusion thesis — frequently asked questions

How many MD Immunohaematology & Blood Transfusion thesis topics are listed here?

220+ MD Immunohaematology & Blood Transfusion thesis topics are listed on this page, organised by subsection of the Immunohaematology & Blood Transfusion curriculum. Click "Get Objectives" on any title to unlock its aim, objectives and hypothesis instantly.

Do these Immunohaematology & Blood Transfusion topics include the objective and synopsis?

Yes. "Get Objectives" unlocks the research question, aim, primary and secondary objectives, hypothesis and outcome measures. "Full Plan" unlocks the complete synopsis: introduction, review of literature search terms, methodology, sample-size calculation, statistical plan, ethics and timeline — ready to download as Word or PDF.

Are these topics suitable for DNB, MD and FCPS Immunohaematology & Blood Transfusion candidates?

Yes — these Immunohaematology & Blood Transfusion dissertation titles are aligned with NMC, NBE and DNB Immunohaematology & Blood Transfusion curricula and are suitable for MD Immunohaematology & Blood Transfusion, DNB Immunohaematology & Blood Transfusion and FCPS candidates alike. We can also tailor a title to your institution's preferred study design.

Can you help with synopsis writing, protocol, data analysis and journal publication?

Yes. Beyond topic selection we provide end-to-end support: synopsis writing (NMC / NBE format), IEC / IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS / R / STATA), full thesis writing, plagiarism check (Turnitin), and journal publication assistance (SCOPUS, UGC-CARE, PubMed-indexed).

How fast can I get the objective for a topic?

Instantly. After payment, the objectives open on screen in under a minute and the full plan in 1–3 minutes, 24×7. You can also click "WhatsApp" on any title to talk to our team.

WhatsApp